Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|September 1, 2022
Targeting TRAF3IP2 inhibits angiogenesis in glioblastomaAmin Izadpanah, Fatemeh Daneshimehr, Kurtis Willingham, et al.
Cardiovascular Diabetology|April 22, 2021
Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffnessAnnayya R Aroor, Srinivas Mummidi, Juan Carlos Lopez-Alvarenga, et al.
Cellular Signalling|July 23, 2013
TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiationAnthony J Valente, Siva S V P Sakamuri, Jalahalli M Siddesha, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 29, 2012
Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18Anthony J Valente, Tadashi Yoshida, Subramanyam N Murthy, et al.
Journal of Cellular Physiology|December 8, 2007
Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activationVenkatapuram Seenu Reddy, Ralf Egan Harskamp, Margreet Willie van Ginkel, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 24, 2016
Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima FormationYan Ji, Zhen Weng, Philip Fish, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 5, 2019
Angiotensin II suppresses autophagy and disrupts ultrastructural morphology and function of mitochondria in mouse skeletal muscleKleiton Augusto Santos Silva, Thaysa Ghiarone, Kathy Schreiber, et al.
Pageof 11